EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 99 filers reported holding EPIZYME INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,239,000 | +26.1% | 275,000 | 0.0% | 0.30% | +14.7% |
| Q2 2017 | $4,153,000 | -11.9% | 275,000 | 0.0% | 0.26% | -17.0% |
| Q1 2017 | $4,716,000 | +41.7% | 275,000 | 0.0% | 0.31% | +43.8% |
| Q4 2016 | $3,328,000 | +23.0% | 275,000 | 0.0% | 0.22% | +31.5% |
| Q3 2016 | $2,706,000 | -3.9% | 275,000 | 0.0% | 0.16% | -4.1% |
| Q2 2016 | $2,816,000 | -15.5% | 275,000 | 0.0% | 0.17% | -7.5% |
| Q1 2016 | $3,333,000 | – | 275,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |